Abstract
Constructing, evaluating, and interpreting gene networks generally sits within the broader field of systems biology, which continues to emerge rapidly, particular with respect to its application to understanding the complexity of signaling in the context of cancer biology. For the purposes of this volume, we take a broad definition of systems biology. Considering an organism or disease within an organism as a system, systems biology is the study of the integrated and coordinated interactions of the network(s) of genes, their variants both natural and mutated (e.g., polymorphisms, rearrangements, alternate splicing, mutations), their proteins and isoforms, and the organic and inorganic molecules with which they interact, to execute the biochemical reactions (e.g., as enzymes, substrates, products) that reflect the function of that system. Central to systems biology, and perhaps the only approach that can effectively manage the complexity of such systems, is the building of quantitative multiscale predictive models. The predictions of the models can vary substantially depending on the nature of the model and its inputoutput relationships. For example, a model may predict the outcome of a specific molecular reaction(s), a cellular phenotype (e.g., alive, dead, growth arrest, proliferation, and motility), a change in the respective prevalence of cell or subpopulations, a patient or patient subgroup outcome(s). Such models necessarily require computers. Computational modeling can be thought of as using machine learning and related tools to integrate the very high dimensional data generated from modern, high throughput omics technologies including genomics (next generation sequencing), transcriptomics (gene expression microarrays; RNAseq), metabolomics and proteomics (ultra high performance liquid chromatography, mass spectrometry), and “subomic” technologies to study the kinome, methylome, and others. Mathematical modeling can be thought of as the use of ordinary differential equations and related tools to create dynamic, semi-mechanistic models of low dimensional data including gene/protein signaling as a function of time/dose. More recently, the integration of imaging technologies into predictive multiscale modeling has begun to extend further the scales across which data can be obtained and used to gain insight into system function.
There are several goals for predictive multiscale modeling including the more academic pursuit of understanding how the system or local feature thereof is regulated or functions, to the more practical or translational goals of identifying predictive (selecting which patient should receive which drug/therapy) or prognostic (disease progress and outcome in an individual patient) biomarkers and/or identifying network vulnerabilities that represent potential targets for therapeutic benefit with existing drugs (including drug repurposing) or for the development of new drugs. These various goals are not necessarily mutually exclusive or inclusive.
Within this volume, readers will find examples of many of the activities noted above. Each chapter contains practical and/or methodological insights to guide readers in the design and interpretation of their own and published work.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Lecca P, Re A (2016) Network-oriented approaches to anticancer drug response. Methods Mol Biol—Cancer Gene Netw 1513:101–115
Kim JY, Gatenby R (2016) Quantitative clinical imaging methods for monitoring intratumoral evolution. Methods Mol Biol—Cancer Gene Netw 1513:61–79
Verma N, Zhu Z, Hangfu D (2016) CRISPR/Cas-mediated knockin in human pluripotent stem cells. Methods Mol Biol—Cancer Gene Netw 1513:119–139
Miller DFB, Yan P, Fang F et al (2016) Complete transcriptome RNA-Seq. Methods Mol Biol—Cancer Gene Netw 1513:141–162
Wang J, Ye Z, Huang TH et al (2016) Computational methods and correlation of exon-skipping events with splicing, transcription and epigenetic factors. Methods Mol Biol—Cancer Gene Netw 1513:163–170
Zhang W, Lee WY, Zilberberg J (2016) Tissue engineering platforms to replicate the tumor microenvironment of multiple myeloma. Methods Mol Biol—Cancer Gene Netw 1513:171–189
Ritchie W (2016) microRNA target prediction. Methods Mol Biol—Cancer Gene Netw 1513:193–199
Nguyen C, West GM, Geoghegan KF (2016) Emerging methods in chemoproteomics with relevance to drug discovery. Methods Mol Biol—Cancer Gene Netw 1513:11–21
Haznadar M, Mathé E (2016) Experimental and study design considerations in uncovering oncometabolites. Methods Mol Biol—Cancer Gene Netw 1513:37–46
Marschall AL, Zhang C, Dübel S (2016) Evaluating the delivery of proteins to the cytosol of mammalian cells. Methods Mol Biol—Cancer Gene Netw (this volume)
Jozwik C, Eidelman O, Starr J et al (2016) Validation of biomarker proteins using reverse capture protein microarrays. Methods Mol Biol—Cancer Gene Netw 1513:201–207
Clarke R, Cook KL, Hu R et al (2012) Endoplasmic reticulum stress, the unfolded protein response, autophagy, and the integrated regulation of breast cancer cell fate. Cancer Res 72:1321–1331
Higgins R, Gendron JM, Rising L et al (2015) The unfolded protein response triggers site-specific regulatory ubiquitylation of 40S ribosomal proteins. Mol Cell 59:35–49
Schwartz-Roberts JL, Cook KL, Chen C et al (2015) Interferon regulatory factor-1 signaling regulates the switch between autophagy and apoptosis to determine breast cancer cell fate. Cancer Res 75:1046–1055
Cook KL, Wärri A, Soto-Pantoja DR et al (2014) Chloroquine inhibits autophagy to potentiate antiestrogen responsiveness in ER+ breast cancer. Clin Cancer Res 20:3222–3232
Clarke R, Tyson JJ, Dixon JM (2015) Endocrine resistance in breast cancer—an overview and update. Mol Cell Endocrinol (in press)
Mooneyham A, Bazzaro M (2016) Targeting deubiquitinating enzymes and autophagy in cancer. Methods Mol Biol—Cancer Gene Netw 1513:49–57
Li G, Yuan L, Zhuang Z (2016) Chemical synthesis of activity-based diubiquitin probes. Methods Mol Biol—Cancer Gene Netw 1513:223–232
Gomez BP, Riggins R, Shajahan AN et al (2007) Human X-Box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines. FASEB J 21:4013–4027
Davies MP, Barraclough DL, Stewart C et al (2008) Expression and splicing of the unfolded protein response gene XBP-1 are significantly associated with clinical outcome of endocrine-treated breast cancer. Int J Cancer 123:85–88
Hu R, Warri A, Jin L et al (2015) NFkappaB signaling is required for XBP1 (U and S) mediated effects on antiestrogen responsiveness and cell fate decisions in breast cancer. Mol Cell Biol 35:379–390
Feldman HC, Maly DJ (2016) Profiling the dual enzymatic activities of the serine/threonine kinase IRE1a. Methods Mol Biol—Cancer Gene Netw 1513:233–241
Leighton X, Eidelman O, Jozwik C et al (2016) ANXA7-GTPase as tumor suppressor: mechanism and therapeutic opportunities. Methods Mol Biol—Cancer Gene Netw 1513:23–33
Day TF, Mewani RR, Starr J et al (2016) Transcriptome and proteome analyses of TNFAIP8 knockdown in cancer cells reveal new insights into molecular determinants of cell survival and tumor progression. Methods Mol Biol—Cancer Gene Netw 1513:83–99
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Clarke, R. (2017). Introduction: Cancer Gene Networks. In: Kasid, U., Clarke, R. (eds) Cancer Gene Networks. Methods in Molecular Biology, vol 1513. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6539-7_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6539-7_1
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6537-3
Online ISBN: 978-1-4939-6539-7
eBook Packages: Springer Protocols